Novavax Appoints Mark Twyman Vice President Marketing
(Thomson Reuters ONE) -
GAITHERSBURG, Md., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced the appointment of Mark Twyman to the position of
Vice President, Marketing. Mr. Twyman's efforts will be focused on the
commercial launch of the company's RSV F Vaccine.
Mr. Twyman joins Novavax with more than 20 years of experience commercializing
healthcare products including key roles at Merck, MedImmune and Genzyme. His
eighteen year tenure at Merck included 12 years in the Merck Vaccine Division,
where he held roles of increasing responsibility, including Vice President,
Global Marketing for the pediatric vaccine franchise. At MedImmune he served as
Vice President and General Manager for the influenza program. Mr. Twyman earned
an M.B.A. from The Wharton School of the University of Pennsylvania and a
Bachelor of Arts degree from Dickinson College.
"We are delighted to welcome Mark to our team," said John Trizzino, Senior Vice
President, Commercial Operations. "His depth of experience in vaccine marketing
and commercialization efforts will be an important asset as Novavax prepares to
bring its RSV F Vaccine franchise to market."
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is available
on the company's website, novavax.com.
Contact: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir(at)novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull(at)russopartnersllc.com
todd.davenport(at)russopartnersllc.com
212-845-4271
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire
[HUG#1975234]
Unternehmensinformation / Kurzprofil:
Datum: 21.12.2015 - 22:05 Uhr
Sprache: Deutsch
News-ID 441164
Anzahl Zeichen: 2895
contact information:
Town:
Maryland
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 393 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novavax Appoints Mark Twyman Vice President Marketing"
steht unter der journalistisch-redaktionellen Verantwortung von
Novavax, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
